Federated Hermes
MIRM icon

Federated Hermes’s Mirum Pharmaceuticals MIRM Stock Holding History

Federated Hermes’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.1M Sell
436,635
-69,576
-14% -$6.99M 0.07% 268
2026
Q1 		$46.8M Buy
506,211
+24,250
+5% +$2.28M 0.08% 272
2025
Q4 		$38.1M Buy
481,961
+135,439
+39% +$9.72M 0.06% 315
2025
Q3 		$25.4M Buy
346,522
+2,218
+0.6% +$141K 0.04% 388
2025
Q2 		$17.5M Sell
344,304
-3,062
-0.9% -$136K 0.03% 454
2025
Q1 		$15.6M Buy
347,366
+343,725
+9,440% +$16.2M 0.03% 455
2024
Q4 		$151K Sell
3,641
-359
-9% -$15K ﹤0.01% 1526
2024
Q3 		$156K Sell
4,000
-1,400
-26% -$55.8K ﹤0.01% 1519
2024
Q2 		$185K Sell
5,400
-3,600
-40% -$94.4K ﹤0.01% 1492
2024
Q1 		$226K Buy
9,000
+4,000
+80% +$110K ﹤0.01% 1471
2023
Q4 		$148K Sell
5,000
-15,544
-76% -$470K ﹤0.01% 1550
2023
Q3 		$649K Buy
20,544
+8,544
+71% +$234K ﹤0.01% 1261
2023
Q2 		$310K Hold
12,000
– – ﹤0.01% 1491
2023
Q1 		$288K Buy
12,000
+2,000
+20% +$45.6K ﹤0.01% 1531
2022
Q4 		$195K Buy
10,000
+9,985
+66,567% +$197K ﹤0.01% 1561
2022
Q3 		$1K Sell
15
-15
-50% -$361 ﹤0.01% 2060
2022
Q2 		$1K Sell
30
-19,955
-100% -$471K ﹤0.01% 2058
2022
Q1 		$440K Buy
+19,985
New +$408K ﹤0.01% 1481
2019
Q4 		– Sell
-29,232
Closed -$294K – 2267
2019
Q3 		$294K Buy
+29,232
New +$359K ﹤0.01% 1525

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's MIRM Position: Q2 2026 in Review

Federated Hermes reduced its Mirum Pharmaceuticals (MIRM) stake by 14% in Q2 2026, selling an estimated $6.99M and leaving 436,635 shares worth $51.1M. The position accounts for 0.07% of the portfolio, ranked #268.

Federated Hermes first reported a position in MIRM in Q3 2019 and has held it in 19 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Federated Hermes held 436,635 shares of Mirum Pharmaceuticals worth $51.1M as of Q2 2026.
  • Federated Hermes sold 69,576 Mirum Pharmaceuticals shares in Q2 2026, an estimated $6.99M.
  • Mirum Pharmaceuticals made up 0.07% of Federated Hermes's portfolio in Q2 2026, its #268 holding.
  • Federated Hermes first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 19 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.